PHARMACEUTICAL PRODUCT DEVELOPMENT INC Deferred Tax Assets, Net of Valuation Allowance, Current
PHARMACEUTICAL PRODUCT DEVELOPMENT INC had Deferred Tax Assets, Net of Valuation Allowance, Current of $41.33 million as of 2011-09-30, per its 10-Q filed 2011-11-02.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxAssetsNetCurrent · last filed 2011-11-02
- 2011-09-30: Deferred Tax Assets, Net of Valuation Allowance, Current $41.33M.
- 2011-06-30: Deferred Tax Assets, Net of Valuation Allowance, Current $31.98M.
- 2011-03-31: Deferred Tax Assets, Net of Valuation Allowance, Current $32.97M.
- 2010-12-31: Deferred Tax Assets, Net of Valuation Allowance, Current $30.91M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance, Current |
|---|---|
| 2011-09-30 | $41.33M 10-Q · filed 2011-11-02 |
| 2011-06-30 | $31.98M 10-Q · filed 2011-08-04 |
| 2011-03-31 | $32.97M 10-Q · filed 2011-05-03 |
| 2010-12-31 | $30.91M 10-Q · filed 2011-11-02 |
| 2010-09-30 | $25.87M 10-Q · filed 2010-11-05 |
| 2010-06-30 | $26.73M 10-Q · filed 2010-08-06 |
| 2009-12-31 | $26.07M 10-K · filed 2011-02-25 |